CALGARY, AB , Nov. 24, 2025 /CNW/ - Nanalysis Scientific Corp . ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications, announces third quarter results for the period ending on September 30 , 2025. Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 4:15 P.M. Eastern... Read More

Hosting Call at 4:15 pm ET on Monday, November 24th CALGARY, AB , Nov. 18, 2025 /CNW/ - Nanalysis Scientific Corp. ("the Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications announces that on Monday, November 24th, 2025, the Company will put out a press release at the market close and Chief Executive Officer Sean... Read More

CALGARY, AB , Nov. 14, 2025 /CNW/ - Nanalysis Scientific Corp. (the " Company " or " Nanalysis ") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), announces that Randall McRae has resigned as Chief Financial Officer of the Company effective December 5, 2025 . Mr. McRae will continue to serve as the Chief Financial Officer until his departure, and will remain available to the company on an advisory basis going forward. Heather Kury ,... Read More

CALGARY, AB , Oct. 7, 2025 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable Nuclear Magnetic Resonance (NMR) instruments and Magnetic Resonance Imaging (MRI) technology for industrial and research applications, announced new file support from Wiley, a global leader in authoritative content and research intelligence, in their KnowItAll 2026 software release for... Read More

CALGARY, AB , Sept. 3, 2025 /PRNewswire/ - Nanalysis Scientific Corp . ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable Nuclear Magnetic Resonance (NMR) instruments and Magnetic Resonance Imaging (MRI) technology for industrial and research applications, has entered into a licensing agreement with IMRIS Imaging, Inc. ("IMRIS"). The Company and IMRIS have signed a multi-pronged five-year OEM... Read More

CALGARY, AB , Aug. 28, 2025 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications announces second quarter results for the period ending on June 30 , 2025. Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5 P.M. Eastern Time... Read More

Hosting Call at 5:00 pm ET on Thursday , August 28th European Q&A Session on Friday, August 29th at 8:30am ET CALGARY, AB , Aug. 21, 2025 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications announces that on Thursday, August 28th, 2025, the Company will put out a press release... Read More

CALGARY, AB , July 9, 2025 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and MRI technology for industrial and research applications announces the publication in the National Formulary of the first regulatory certified assay for benchtop NMR – the Molar Substitution Determination in Hydroxypropyl Betadex USP-NF/Ph. Euro (1804) . "Currently... Read More

CALGARY, AB , June 13, 2025 /CNW/ - Nanalysis Scientific Corp. (the " Company " or " Nanalysis ") (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that it has closed its previously-announced offering of 12% unsecured promissory notes (the " Notes ") for aggregate gross proceeds of $2,000,000 (the " Offering "). The Notes were issued to arm's length third-party investors (the " Lenders "). The Notes mature on June... Read More

CALGARY, AB , June 6, 2025 /CNW/ - Nanalysis Scientific Corp. (the " Company " or " Nanalysis ") ( TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ) , is pleased to announce that its previously disclosed offering of 12% unsecured promissory notes (the " Notes ") for aggregate gross proceeds of $2,000,000 (the " Offering ") is now fully subscribed. As part of the Offering, the Company will issue an aggregate of 1,600,000 bonus common... Read More

CALGARY, AB , June 6, 2025 /CNW/ - Nanalysis Scientific Corp. (the " Company " or " Nanalysis ") (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce an offering of 12% unsecured promissory notes (the " Notes ") for aggregate gross proceeds of $2,000,000 (the " Offering "). The Notes will be issued to arm's length third-party investors (the " Lenders "). The Notes will bear simple interest at a rate of 12% per annum,... Read More

Delivers Another Quarter of Positive Adjusted EBITDA & Operating Cash Flow CALGARY, AB , May 28, 2025 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications announces first quarter results for the period ending on March 31 , 2025. Chief Executive Officer Sean Krakiwsky and Chief Financial... Read More

Hosting Call at 5:00 pm ET on Wednesday , May 28th European Q&A Session on Thursday, May 29th at 8:30am ET CALGARY, AB , May 15, 2025 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications that on Wednesday, May 28th, 2025, the Company will put out a press release and Chief... Read More

Company Achieves Record Quarterly Revenue of $12 .3MM and Adjusted EBITDA of $1 .8MM Reports Record Annual Revenue of $45MM and Adjusted EBITDA of $2 .8MM CALGARY, AB , April 24, 2025 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications announces fourth quarter and full year results for the... Read More

Hosting Call at 5:00 pm ET on Thursday , April 24th European Q&A Session on Friday, April 25th at 8:30am ET CALGARY, AB , April 17, 2025 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications that on Thursday, April 24th, 2025, the Company will put out a press release and Chief... Read More

Provides Ease of Use and Reduces Expertise Required to Collect Data CALGARY, AB , March 18, 2025 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications, announces the release of automation software to reduce the barrier of expertise required to generate quantitative data. "It has... Read More

Debuting at Pittcon Conference and Expo in Boston, MA March 1-5th CALGARY, AB , March 5, 2025 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications, announces the launch of its 60... Read More

Achieves Record Quarterly Adjusted EBITDA of at least $1 Million & Positive Free Cash-Flow CALGARY, AB , Feb. 27, 2025 /CNW/ - Nanalysis Scientific Corp. "the Company", (TSXV: NSCI), (OTCQX: NSCIF), (FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications,... Read More

CALGARY, AB , Dec. 11, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and MRI technology for industrial and research applications announces results of study by the United States Pharmacopeia (USP) concluding that benchtop NMR is efficacious for quality control of active pharmaceutical ingredients (API). "In the not-too-distant future, we... Read More

Company Achieved 50% YoY Revenue Growth & Positive EBITDA CALGARY, AB , Nov. 21, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces third quarter results for the period ending on September 30, 2024 , achieving 50% year-over-year revenue growth to $10.6 million in Q3. Chief... Read More

Hosting Call at 5:00 pm ET on Thursday, November 21st European Q&A Session on Friday, November 22nd at 8:30am ET CALGARY, AB , Nov. 7, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Thursday, November 21st, 2024, the Company will put out a press release and Chief... Read More

Presentation at 3:00 PM PT /6:00 PM ET on Wednesday, October 30th CALGARY, AB , Oct. 15, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that Chief Executive Officer Sean Krakiwsky will be presenting at the 17 th annual Main Event on Wednesday, October 30 th at 3:00PM PT at the... Read More

Calgary, Alberta--(Newsfile Corp. - October 3, 2024) - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF), a leader in portable NMR machines and MRI technology for industrial and research applications, is pleased to announce its participation at the upcoming Cantech Letter Investment Conference on Wednesday, October 9, 2024 in Toronto Ontario. Sean Krakiwsky, Chief Executive Officer of Nanalysis Scientific Corp. will be... Read More

Record Revenue and Positive EBITDA CALGARY, AB , Aug. 28, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces second quarter results for the period ending on June 30, 2024 , achieving 65% year-over-year revenue growth to $11.5 million in Q2. Chief Executive Officer Sean Krakiwsky... Read More

Hosting Call at 5:00 pm ET on Wednesday , August 28th European Q&A Session on Thursday August 29th at 8:30am ET CALGARY, AB , Aug. 14, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Wednesday, August 28th, 2024, the Company will put out a press release and Chief... Read More

CALGARY, AB , June 28, 2024 /CNW/ - Nanalysis Scientific Corp. (" Nanalysis " or the " Company ", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased ‎to report that all proposed resolutions were approved at the Company's Annual General ‎and Special Meeting of shareholders held on June 26, 2024 (the "Meeting"). The number ‎of directors was set at 6 and all director nominees, as listed in the Management ‎Information Circular... Read More

CALGARY, AB , June 7, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), announces that the Company's Board of Directors has granted a 1,035,000 stock options (the "Options") to its directors and officers, as well as an additional 1,202,000 Options to employees and advisors, pursuant to the Company's stock option plan. Each Option is exercisable to purchase one common share in the... Read More

Company Achieves Record Revenue Quarter CALGARY, AB , May 29, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications announces first quarter results for the period ending on March 31, 2024 , achieving 139% year-over-year revenue growth to $11.2 million in Q1. Chief Executive Officer, Sean... Read More

Hosting Call at 5:00 pm ET on Wednesday , May 29th European Q&A Session on Thursday May 30th at 8:30am ET CALGARY, AB , May 21, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Wednesday, May 29th, 2024, the Company will put out a press release and Chief Executive Officer... Read More

CALGARY, AB , April 29, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces fourth quarter and full year results for the period ending on December 31 , 2023. Chief Executive... Read More

In the news release, Nanalysis Announces Full Year 2023 Conference Call, issued 11-Apr-2024 by Nanalysis Scientific Corp. over CNW, we are advised by the company that the Hosting Call and European Q&A Session date mentioned should read " Monday, April 29th and Tuesday, April 30th respectively" rather than " Thursday April 25th and Friday April 26th respectively" as originally issued inadvertently. The complete, corrected... Read More

Hosting Call at 5:00 pm ET on Thursday , April 25th European Q&A Session on Friday April 26 th at 8:30am ET CALGARY, AB , April 11, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) ( FRA: 1 N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Thursday, April 25th, 2024, the Company will put out a press release and Chief... Read More

CALGARY, AB , April 10, 2024 /CNW/ - Nanalysis Scientific Corp. (" Nanalysis " or the " Company ", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) announces that Kham Lin has resigned as a director of the Company effective April 9, 2024 , and the Board of Directors has accepted his resignation. The Company would like to thank Mr. Lin for his contributions throughout his tenure as director of the Company. About Nanalysis Scientific... Read More

CALGARY, AB , April 4, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that its subsidiary Nanalysis Corp. is receiving advisory services and up to $1.45 million in non-repayable, non-dilutive funding from the National Research... Read More

CALGARY, AB , March 20, 2024 /CNW/ - Nanalysis Scientific Corp. (TSXV: NSCI) (the " Company " or " Nanalysis ") is pleased to announce that it has closed its prospectus exempt offering of units (the " Offering ") and concurrent brokered "best efforts" prospectus exempt offering of units (the " Concurrent Offering" ), as announced on March 6, 2024 . A total of 11,111,110 units (the " Units ") were issued at a price of $0.45... Read More

CALGARY, AB , March 6, 2024 /CNW/ - Nanalysis Scientific Corp. (TSXV: NSCI) (the " Company " or " Nanalysis Scientific ") is pleased to announce a best efforts prospectus exempt offering (the " Offering ") of up to 11,111,111 units (the " Units ") of the Company at a price of $0.45 per Unit (the " Issue Price ") for gross proceeds of up to $5,000,000 , pursuant to the listed issuer financing exemption available under Part 5A... Read More

CALGARY, AB , Feb. 7, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that Founder and CEO Sane Krakiwsky will be participating in an upcoming webinar and conference. Event: Radius Research Pitch, Deep Dive, and Q&A with Nanalysis... Read More

CALGARY, AB , Feb. 6, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, provides an estimate of Q4 2023 unaudited revenue and highlights some other recent business accomplishments. Sean Krakiwsky , Founder and CEO of Nanalysis , states: "We are... Read More

Phase-In of Canada-Wide Coverage at All 89 Designated Airports Completed on January 11 , 2024 CALGARY, AB , Jan. 30, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, gives an update on its subsidiary K'(Prime) Technologies ("KPrime") security... Read More

CALGARY, AB , Jan. 3, 2024 /CNW/ - Nanalysis Scientific Corp. ( TSXV:NSCI , OTCQX:NSCIF, FRA:1N1 ) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted 475,000 Restricted Share Units ("RSU"s) to its independent Directors, pursuant to the Company's RSU plan. Each RSU is exercisable for one common share in the capital of the Company for a period ending at the end of the calendar year,... Read More

CALGARY, AB , Nov. 29, 2023 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its third quarter results ending September 30, 2023. Chief Executive Officer, Sean Krakiwsky, and Chief Financial Officer, Randall McRae, will host a conference call at 5 P.M. Eastern Time today to discuss... Read More

Hosting Call at 5:00 pm ET on Wednesday, November 29th European Q&A Session on November 30th at 8:30am ET CALGARY, AB , Nov. 15, 2023 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Wednesday, November 29th, 2023, the Company will put out a press release and Chief Executive... Read More